Weitere Formate
Hardcover - 9781588291301
213,99 €
Autorenfreundlich Bücher kaufen?!
Beschreibung
In this second edition of his highly acclaimed book, Christopher P. Cannon, MD, and a team of preeminent clinical investigators have thoroughly revised and expanded every chapter to reflect the recent explosion of clinical trials on the management of acute coronary syndromes (ACS). This includes: the newer tests, such as C reactive protein; a multimarker approach to diagnosis and risk stratification; new antiplatelet agents; and combinations of thrombolytic-antithrombotic regimens. Also discussed are the latest developments in interventional cardiology, the use of cost-effectiveness in clinical trials to choose appropriate therapies, and the employment of critical pathways analysis to improve compliance with evidence-based medicine and guideline recommendations.
Details
| Verlag | Humana Press |
| Ersterscheinung | 04. November 2002 |
| Maße | 25.4 cm x 17.8 cm |
| Gewicht | 1475 Gramm |
| Format | Softcover |
| ISBN-13 | 9781588293091 |
| Seiten | 783 |
Schlagwörter
Herstellerinformationen
Bekannt durch
